AtroPIM Delivers End-to-End Amazon Integration, Now Including A+ Content

AtroPIM connects your product data directly to Amazon, now with A+ Content support, so your listings stay accurate, ...

Claude Subscriptions Will No Longer Cover Usage On 'Third-Party Tools'—Anthropic Cuts OpenClaw Access Amid Surging AI Demand

Anthropic said it will stop covering usage of its AI model Claude on certain third-party tools, including OpenClaw, under ...

ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja(R)/Fetcroja(R) (cefiderocol) in MBL-Producing Enterobacterales Infections

Data presented at the same congress reinforced cefiderocol's effectiveness against Stenotrophomonas maltophilia, with a subgroup analysis of 119 patients from the PROVE study demonstrating clinical ...
Insurance Business America

A creative mind’s impact on Canada’s MGA evolution

It was the dawn of the digital revolution, desktop publishing, Photoshop, and creative power shifting from specialized shops to everyday professionals. The timing couldn’t have been better. Creativity ...
PharmiWeb

ESCMID Global 2026: Shionogi Presents New Real-World Data Highlighting Clinical Effectiveness of Fetroja®/Fetcroja® (cefiderocol) in MBL-Producing Enterobacterale…

Real-world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day ...
eWeek

Claude Cheat Sheet: A Complete Guide to Anthropic’s AI

Claude is Anthropic’s AI assistant for writing, coding, analysis, and enterprise workflows, with newer tools such as Claude ...

Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides

SHELTON, CT / ACCESS Newswire / April 7, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of ...